Scleroderma Quebec raises $ 240 000 for research and patient support

15 November 2016

For immediate release

Montreal, November 1st, 2016 – Scleroderma Quebec raised more than $ 240 000 during its benefit evening which was held at Montreal’s Cabaret du Casino on November 1st. The funds will be used to support patients who have scleroderma and to finance the research required to find a cure.  The event was organized under the Honorary Presidency of Mr. François Armand, RBC Royal Bank’s Regional Vice-President of Commercial Financial Services, Quebec Branch.  About 500 people attended the dinner-show starring Robert Charlebois who came back one more time this year by popular demand.

Nutrition and Recipe Book

15 November 2016

Nutrition and recipe book for people with scleroderma

It can be a challenge to know what to eat for the betterment of one’s health.  This is particularly true for those affected by the numerous symptoms of scleroderma.

Here’s a practical guide that is exclusive to Scleroderma Quebec!  It is written by Mrs. Audrey Potvin, a dietetic technician and coordinator for Scleroderma Quebec’s support network.  The guide brings together informative texts about different scleroderma symptoms and contains more than thirty healthy recipes that relate to each theme touched on.  A delicious way to improve your quality of life by enjoying simple and healthy food!

If you would like to order a copy in either English or French at a cost of $30 (including postage), please contact Mrs. Audrey Potvin by email:

Warm regards,

The Scleroderma Quebec Team

Scleroderma Support Group Survey

23 April 2015

Do you have scleroderma? Are you interested in helping advance research on scleroderma support groups? If so, please lend a hand by completing this short 10-15 minute survey!  (more…)

New drug approved for the treatment of pulmonary arterial hypertension

4 December 2014

Pulmonary arterial hypertension (PAH) is a common, serious complication of Scleroderma which can quickly lead to death if left untreated. Opsumit® (macitentan), a new treatment option, was shown to be effective in reducing morbidity and mortality in adult patients with PAH. (more…)